Optimizing the Cell Painting assay for image-based profiling

Beth A. Cimini(Broad Institute), Anne E. Carpenter(Broad Institute), Briana Fritchman(Broad Institute), Elizabeth Mouchet(AstraZeneca (United Kingdom)), Tiziana Monteverde(AstraZeneca (Germany)), Bolek Zapiec(Merck KGaA, Darmstadt (Germany)), Srinivas Niranj Chandrasekaran(Broad Institute), Patrick J. Byrne(Broad Institute), Susanne E. Swalley(Biogen (United States)), Santosh Hariharan(Pfizer (United States)), Nasim Jamali(Broad Institute), James Pilling(AstraZeneca (United Kingdom)), David J. Logan(Pfizer (United States)), Erin Weisbart(Broad Institute), Guy Williams, Charles-Hugues Lardeau(Janssen (Belgium)), Shan Yu(Takeda (United States)), Amy Goodale(Broad Institute), John Concannon, Tamara J. Gilbert(Pfizer (United States)), David Gnutt(Bayer (Germany)), Michelle Melanson(Broad Institute), Lisa Miller(Broad Institute), Shantanu Singh(Broad Institute), Desiree Hernandez(Broad Institute), Gisela Hormel(Merck KGaA, Darmstadt (Germany)), Maria Kost‐Alimova(Broad Institute), Anita Vrcic(Broad Institute), Sakshi Garg(Merck KGaA, Darmstadt (Germany)), Adam Skepner(Broad Institute), Karolina Juhani(AstraZeneca (United Kingdom)), Lewis Mervin(AstraZeneca (United Kingdom)), Peter Aspesi, Hamdah Shafqat Abbasi(Broad Institute), Justin D. Boyd(Pfizer (United States))
Nature Protocols
June 21, 2023
Cited by 156


Related Papers